The AdvaMed Code of Ethics on Interactions with U.S. Health Care Professionals sets voluntary standards for company-funded education, consulting, meals, gifts, and research support, complementing federal anti-kickback and Sunshine Act requirements. The Code covers areas like company-sponsored training, support for third-party conferences, consulting arrangements at fair market value, modest meals tied to educational content, and a ban on entertainment and most gifts. Companies certify compliance and are expected to train staff and audit interactions. The Code is not law, but enforcement agencies and courts look at it when judging whether conduct was reasonable.

Why it matters

Adopting and certifying compliance with the Code is a baseline expectation for U.S. MedTech commercial operations. MedTech Europe Code plays an analogous role in Europe.

Common pitfalls

•Failing to understand that voluntary codes, like the AdvaMed Code, often become de facto industry standards that regulators expect companies to follow.
•Assuming that adherence to the AdvaMed Code alone guarantees compliance with all federal and state anti-kickback laws, which have broader applicability and stricter penalties.
•Neglecting to update internal policies and training programs to reflect changes in the AdvaMed Code or evolving interpretations by regulatory bodies.
•Treating the AdvaMed Code as purely legal guidance rather than an ethical framework that shapes company culture and professional conduct.
•Misinterpreting the "appropriate" nature of educational or consulting engagements, leading to interactions that could be perceived as inducements.

Sources

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.